JP2877976B2 - Optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and method for producing the same - Google Patents

Optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and method for producing the same

Info

Publication number
JP2877976B2
JP2877976B2 JP6239391A JP6239391A JP2877976B2 JP 2877976 B2 JP2877976 B2 JP 2877976B2 JP 6239391 A JP6239391 A JP 6239391A JP 6239391 A JP6239391 A JP 6239391A JP 2877976 B2 JP2877976 B2 JP 2877976B2
Authority
JP
Japan
Prior art keywords
trimethyl
formula
cyclohexen
compound
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP6239391A
Other languages
Japanese (ja)
Other versions
JPH04278097A (en
Inventor
謙治 森
プアプーンチャラーン プラパイ
雅通 伊藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HASEGAWA KORYO KK
Original Assignee
HASEGAWA KORYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HASEGAWA KORYO KK filed Critical HASEGAWA KORYO KK
Priority to JP6239391A priority Critical patent/JP2877976B2/en
Publication of JPH04278097A publication Critical patent/JPH04278097A/en
Application granted granted Critical
Publication of JP2877976B2 publication Critical patent/JP2877976B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、新規化合物である
(R)−(+)−2,4,4−トリメチル−2−シクロ
ヘキセン−1−オール及び(S)−(−)−2,4,4
−トリメチル−2−シクロヘキセン−1−オール及びそ
れらの新規製法に関する。本発明によって提供される光
学活性な2,4,4−トリメチル−2−シクロヘキセン
−1−オールは、例えば、香料化合物、農薬などの合成
中間体として極めて有用な化合物である。
The present invention relates to novel compounds (R)-(+)-2,4,4-trimethyl-2-cyclohexen-1-ol and (S)-(-)-2,4. , 4
-Trimethyl-2-cyclohexen-1-ols and their new processes. The optically active 2,4,4-trimethyl-2-cyclohexen-1-ol provided by the present invention is a very useful compound as a synthetic intermediate such as a fragrance compound and an agricultural chemical.

【0002】[0002]

【従来の技術】微生物またはエステル分解酵素を利用す
る不斉加水分解は知られており、例えば豚の肝臓エステ
ラーゼ(以下、PLEという)を用いた不斉加水分解に
よって光学活性なメバロン酸を合成する方法が報告され
ている[J.Am.Chem.Soc.,97,4144
(1975)]。
2. Description of the Related Art Asymmetric hydrolysis using microorganisms or esterases is known. For example, optically active mevalonic acid is synthesized by asymmetric hydrolysis using pig liver esterase (hereinafter referred to as PLE). Methods have been reported [J. Am. Chem. Soc., 97 , 4144.
(1975)].

【0003】[0003]

【発明が解決しようとする課題】しかしながら、2,
4,4−トリメチル−2−シクロヘキセニルアセテート
のラセミ体をエステル分解酵素を用いて不斉加水分解す
ることによって、高純度の光学活性な(R)−(+)−
2,4,4−トリメチル−2−シクロヘキセン−1−オ
ール及び高純度の(S)−(−)−2,4,4−トリメ
チル−2−シクロヘキセン−1−オールが得られること
に関しては全く知られていない。
SUMMARY OF THE INVENTION However, 2,
By asymmetrically hydrolyzing the racemate of 4,4-trimethyl-2-cyclohexenyl acetate using an esterase, high-purity optically active (R)-(+)-
It is completely known that 2,4,4-trimethyl-2-cyclohexen-1-ol and high-purity (S)-(-)-2,4,4-trimethyl-2-cyclohexen-1-ol can be obtained. Not been.

【0004】[0004]

【課題を解決するための手段】本発明者らは、光学活性
な2,4,4−トリメチル−2−シクロヘキセン−1−
オールを簡便な手段によって高光学純度で製造する方法
を鋭意研究した。その結果、ラセミ体の2,4,4−ト
リメチル−2−シクロヘキセニルアセテートをエステル
分解酵素で不斉加水分解することにより光学的に極めて
高純度の新規な(R)−(+)−及び(S)−(−)−
2,4,4−トリメチル−2−シクロヘキセン−1−オ
ールを合成できることを見いだした。すなわち本発明に
よれば、2,4,4−トリメチル−2−シクロヘキセン
−1−オールの両鏡像体を簡便にしかも高光学純度で合
成することができる。以下本発明の態様を具体的に説明
する。
DISCLOSURE OF THE INVENTION The present inventors have developed optically active 2,4,4-trimethyl-2-cyclohexene-1-yl.
We have intensively studied a method for producing oars with high optical purity by simple means. As a result, the novel (R)-(+)-and () which are optically extremely pure by asymmetric hydrolysis of racemic 2,4,4-trimethyl-2-cyclohexenyl acetate with an esterase. S)-(-)-
It has been found that 2,4,4-trimethyl-2-cyclohexen-1-ol can be synthesized. That is, according to the present invention, both enantiomers of 2,4,4-trimethyl-2-cyclohexen-1-ol can be easily synthesized with high optical purity. Hereinafter, embodiments of the present invention will be specifically described.

【0005】本発明において利用するラセミ体の2,
4,4−トリメチル−2−シクロヘキセニルアセテート
[後記式(4)の化合物]はそれ自体既知の方法によ
り、例えばエチルビニルケトンとイソブチルアルデヒド
から2,4,4−トリメチル−2−シクロヘキセン−1
−オンを合成し、これを還元してアルコールに導き、次
いで酢酸とエステル化とすることによって容易に合成す
ることができる。以下反応工程に沿って順を追って説明
する。
[0005] The racemic 2,2 used in the present invention
4,4-Trimethyl-2-cyclohexenyl acetate [compound of formula (4) below] can be prepared by a method known per se, for example, from ethyl vinyl ketone and isobutyraldehyde by 2,4,4-trimethyl-2-cyclohexene-1.
It can be easily synthesized by synthesizing -one, reducing this to alcohol, and then esterifying with acetic acid. Hereinafter, the reaction steps will be described step by step.

【0006】2,4,4−トリメチル−2−シクロヘキ
セン−1−オンを得るには、例えば市場で容易に入手で
きるエチルビニルケトン1モルとイソブチルアルデヒド
約1.5モルの混合物を約50℃以下の温度に保ちつ
つ、これらの混合物に対して例えば、約0.1〜約10
重量%の硫酸、p−トルエンスルホン酸、塩酸などの強
酸を少量づつ加え、室温にて約1〜約24時間かきまぜ
た後、Dean−Stark trapを装着し、還流
条件下に約1〜約48時間反応を行う。反応終了後残渣
を減圧蒸留することにより2,4,4−トリメチル−2
−シクロヘキセン−1−オンを得ることができる。
To obtain 2,4,4-trimethyl-2-cyclohexen-1-one, for example, a mixture of 1 mol of ethyl vinyl ketone and about 1.5 mol of isobutyraldehyde, which is easily available on the market, is treated at about 50 ° C. or lower. While maintaining a temperature of about 0.1 to about 10
% By weight of a strong acid such as sulfuric acid, p-toluenesulfonic acid, hydrochloric acid, etc., and the mixture is stirred at room temperature for about 1 to about 24 hours. Perform a time reaction. After completion of the reaction, the residue was distilled under reduced pressure to give 2,4,4-trimethyl-2.
-Cyclohexen-1-one can be obtained.

【0007】次いで上記の如くして得られるケトン体を
それ自体既知の方法、例えば、水素化リチウムアルミニ
ウム、セリウムクロライド存在下の水素化ホウ素ナトリ
ウム、水素化ジイソブチルアルミニウム及び水素化アル
ミニウムなどを用いて還元することによりラセミ体の
2,4,4−トリメチル−2−シクロヘキセン−1−オ
ールに導くことができる。
Next, the ketone compound obtained as described above is reduced by a method known per se, for example, using lithium aluminum hydride, sodium borohydride in the presence of cerium chloride, diisobutylaluminum hydride, aluminum hydride and the like. This leads to racemic 2,4,4-trimethyl-2-cyclohexen-1-ol.

【0008】該ラセミ体アルコールの酢酸エステルは、
例えば、ピリジン−無水酢酸法、4−ジメチルアミノビ
リジン−無水酢酸法、燐酸−無水酢酸法またはトリエチ
ルアミン−アセチルクロリド法等の従来既知の酢酸エス
テル化反応を採用することにより、式(4)で表される
化合物(±)−2,4,4−トリメチル−2−シクロヘ
キセニルアセテートに容易に導くことができる。
[0008] The acetate of the racemic alcohol is
For example, by employing a conventionally known acetic acid esterification reaction such as a pyridine-acetic anhydride method, a 4-dimethylaminoviridine-acetic anhydride method, a phosphoric acid-acetic anhydride method, or a triethylamine-acetyl chloride method, the formula (4) is obtained. The compound (±) -2,4,4-trimethyl-2-cyclohexenyl acetate can be easily derived.

【0009】また(±)−2,4,4−トリメチル−2
−シクロヘキセニルアセテート[式(4)の化合物]の
不斉加水分解は下記反応式Aによって行うことができ
る。
Also, (±) -2,4,4-trimethyl-2
The asymmetric hydrolysis of -cyclohexenyl acetate [compound of the formula (4)] can be carried out by the following reaction formula A.

【0010】[0010]

【化8】 Embedded image

【0011】式(4)の化合物1重量部を0.1モル燐
酸バッファー[メタノール、エタノール、イソプロパノ
ール等の極性溶剤約5〜50重量%含有(pH約7〜
8)]約30〜約50重量部に分散させ、そこへエステ
ル分解酵素を約500〜約5000unit添加し、例
えば、約−15〜約+約5℃の温度で約5〜約200時
間激しくかき混ぜて加水分解反応を行う。
One part by weight of the compound of the formula (4) is contained in a 0.1M phosphate buffer [containing about 5 to 50% by weight of a polar solvent such as methanol, ethanol and isopropanol (pH about 7 to 10%).
8)] Disperse in about 30 to about 50 parts by weight, add about 500 to about 5000 units of the esterase, and vigorously stir at a temperature of about −15 to about + 5 ° C. for about 5 to about 200 hours, for example. To carry out a hydrolysis reaction.

【0012】かかるエステル分解酵素としては、例えば
ブタ肝臓エステラーゼ(以下、PELということがあ
る)、ブタすい臓リパーゼ(PPL)等の酵素を挙げる
ことができるが、ブタ肝臓エステラーゼを好ましく挙げ
ることができる。
Examples of such esterases include enzymes such as pig liver esterase (hereinafter sometimes referred to as PEL) and pig pancreatic lipase (PPL). Pig liver esterase is preferred.

【0013】次いで、反応液に食塩、塩化アンモニウム
等を加えて飽和させ、エーテル等で数回抽出する。抽出
液を常法により洗浄し、硫酸ナトリウム、硫酸マグネシ
ウム、塩化カルシウム等の脱水剤を加えて乾燥後、溶媒
を回収除去する。
Then, the reaction solution is saturated with sodium chloride, ammonium chloride and the like, and extracted several times with ether and the like. The extract is washed by a conventional method, and a dehydrating agent such as sodium sulfate, magnesium sulfate, calcium chloride or the like is added and dried, and then the solvent is recovered and removed.

【0014】この反応により、100%e.e.(ena
nthio excess:光学収率)の(R)−
(+)−アルコール体[式(1)の化合物]と約40%
e.e.の(S)−(−)−アセテート[式(3)の化
合物]が1:約2〜約4の割合で生成する。この混合物
は例えば、シリカゲルクロマトグラフィー等によりそれ
ぞれの成分に容易に分離精製することができる。
By this reaction, 100% ee (ena)
(r)-of nthio excess: optical yield
(+)-Alcohol [compound of formula (1)] and about 40%
e. e. (S)-(-)-acetate [compound of formula (3)] is produced in a ratio of about 1: 2 to about 4. This mixture can be easily separated and purified into the respective components by, for example, silica gel chromatography or the like.

【0015】さらに、分離される式(3)の化合物(約
40%e.e.)を前記と同様にエステル分解酵素で再
処理することにより、光学純度ほぼ100%の(S)−
(−)−体に変換することができる。
Further, the compound of formula (3) (about 40% ee) to be separated is re-treated with an esterase in the same manner as described above, whereby (S)-having an optical purity of almost 100%.
(-)-.

【0016】式(3)の化合物から式(2)の化合物を
合成する反応は下記反応式Bによって表される。
The reaction for synthesizing the compound of the formula (2) from the compound of the formula (3) is represented by the following reaction formula B.

【0017】[0017]

【化9】 Embedded image

【0018】式(3)の化合物1重量部を約10〜約2
0重量部のメタノール、エタノール、イソプロパノール
等の溶媒に溶解し、例えば炭酸カリウム、炭酸ナトリウ
ム、水酸化カリウム、水酸化ナトリウム等のアルカリを
加え、室温条件下で約0.1〜約10時間かき混ぜ、反
応終了後減圧下に溶媒を回収除去し、残渣を水で希釈し
てエーテル等で抽出する。抽出物を常法により洗浄し脱
水剤を加えて乾燥後、溶媒を除去することにより粗製の
式(2)の化合物を得ることができる。
1 part by weight of the compound of the formula (3) is added in an amount of about 10 to about 2
0 parts by weight methanol, ethanol, dissolved in a solvent such as isopropanol, for example, potassium carbonate, sodium carbonate, potassium hydroxide, alkali such as sodium hydroxide, and stirred at room temperature for about 0.1 to about 10 hours, After completion of the reaction, the solvent is recovered and removed under reduced pressure, and the residue is diluted with water and extracted with ether or the like. The extract is washed by a conventional method, dried by adding a dehydrating agent, and then removing the solvent to obtain a crude compound of the formula (2).

【0019】次いで、この粗製の式(2)の化合物1重
量部を例えばピリジン、トリエチルアミン等の溶媒約1
0〜約20倍重量部に溶解し、DMAP(4−ジメチル
アミノピリジン)等の触媒を約0.05〜0.2重量部
加え、そこへ3,5−ジニトロベンゾイルクロライド、
3,5,−ジニトロベンゾイルブロマイド等の3,5−
ジニトロベンゾイルハライド約1〜約2重量部を少しづ
つ加える。さらに室温で約1〜約24時間かき混ぜ反応
を行った後、反応液を氷水中に注ぎ、エーテル等で抽出
する。抽出液を常法により洗浄、乾燥した後溶媒を回収
除去し、式(5)の化合物の粗結晶を得ることができ
る。この粗結晶を例えばイソプロピルエーテル等から再
結晶することにより、純粋な式(5)の化合物を得るこ
とができる。
Next, 1 part by weight of the crude compound of the formula (2) is mixed with about 1 part of a solvent such as pyridine, triethylamine or the like.
0 to about 20 parts by weight, and about 0.05 to 0.2 parts by weight of a catalyst such as DMAP (4-dimethylaminopyridine), to which 3,5-dinitrobenzoyl chloride,
3,5- such as 3,5-dinitrobenzoyl bromide
About 1 to about 2 parts by weight of dinitrobenzoyl halide are added in portions. After stirring at room temperature for about 1 to about 24 hours, the reaction solution is poured into ice water and extracted with ether or the like. After the extract is washed and dried by a conventional method, the solvent is recovered and removed to obtain a crude crystal of the compound of the formula (5). By recrystallizing the crude crystals from, for example, isopropyl ether or the like, a pure compound of the formula (5) can be obtained.

【0020】この式(5)の化合物を、例えばメタノー
ル:ジクロロメタン=約1:1の溶媒に溶解し、炭酸カ
リウム、水酸化カリウム、水酸化ナトリウム等のアルカ
リで処理することにより式(2)の化合物を得ることが
できる、更にこれをシリカゲルクロマトグラフィー等に
よって処理することにより光学純度100%e.e.の
(S)−(−)−2,4,4−トリメチル−2−シクロ
ヘキセン−1−オール[式(2)の化合物]を得ること
ができる。以下、参考例、実施例により本発明の態様を
さらに具体的に説明する。
The compound of the formula (2) is dissolved in a solvent of, for example, methanol: dichloromethane = about 1: 1 and treated with an alkali such as potassium carbonate, potassium hydroxide, sodium hydroxide or the like. A compound can be obtained, which is further treated by silica gel chromatography or the like to give an optical purity of 100% e. e. (S)-(-)-2,4,4-trimethyl-2-cyclohexen-1-ol [compound of formula (2)] can be obtained. Hereinafter, embodiments of the present invention will be described more specifically with reference examples and examples.

【0021】[0021]

【参考例1】2,4,4−トリメチル−2−シクロヘキ
セン−1−オンの合成 エチルビニルケトン75.0g(892mmol)とイソ
ブチルアルデヒド96.4g(1.34 mol)の混合物
を50℃以下に保ち、かき混ぜながら濃硫酸2.25m
lを少しづつ加えた。混合液を室温で5時間かき混ぜた
後、Dean−Stark trapを装着し、還流条
件下に16時間反応を行った。残渣を減圧蒸留し、b.
p.54〜55℃/5Torrの2,4,4−トリメチル−
2−シクロヘキセン−1−オン86.2gを得た。
[Reference Example 1]2,4,4-trimethyl-2-cyclohex
Synthesis of sen-1-one  75.0 g (892 mmol) of ethyl vinyl ketone and iso
Mixture of 96.4 g (1.34 mol) of butyraldehyde
2.50m of concentrated sulfuric acid while stirring
1 was added little by little. Stir the mixture at room temperature for 5 hours
Then, a Dean-Stark trap was attached,
The reaction was carried out for 16 hours. The residue was distilled under reduced pressure, b.
2,4,4-trimethyl at p.
86.2 g of 2-cyclohexen-1-one was obtained.

【0022】[0022]

【参考例2】(±)−2,4,4−トリメチル−2−シ
クロヘキセン−1−オールの合成 エーテル800mlに水素化リチウムアルミニウム1
8.5g(486mmol)を溶解し、この溶液をかき混ぜ
ながら0℃に冷却して参考例1で得られたケトン体6
7.1g(486mmol)をエーテル300mlに溶解し
た溶液を滴下した。0℃で1時間かき混ぜた後、水を少
しづつ加えて水素化リチウムアルミニウムを分解した。
固形物を濾過し洗浄後、濾液を濃縮して残渣を減圧蒸留
してb.p.89〜90℃/19Torrの(±)−2,
4,4−トリメチル−2−シクロヘキセン−1−オール
62.8gを得た。
[Reference Example 2](±) -2,4,4-trimethyl-2-si
Synthesis of Clohexen-1-ol  Lithium aluminum hydride 1 in 800 ml of ether
Dissolve 8.5 g (486 mmol) and stir the solution
The ketone body 6 obtained in Reference Example 1 was cooled to 0 ° C.
Dissolve 7.1 g (486 mmol) in 300 ml of ether
The solution was added dropwise. After stirring at 0 ° C for 1 hour,
Then, the lithium aluminum hydride was decomposed.
After filtering and washing the solid, the filtrate is concentrated and the residue is distilled under reduced pressure.
And b. p. 89 ± 90 ° C./19 Torr (±) −2,
4,4-trimethyl-2-cyclohexen-1-ol
62.8 g were obtained.

【0023】[0023]

【参考例3】(±)−2,4,4−トリメチル−2−シ
クロヘキセニルアセテート[式(4)の化合物]の合成 参考例2で得られたラセミ体アルコール61.5g
(439mmol)、無水酢酸67.3g(659mmol)及
びピリジン77mlの混合物をかき混ぜながら0℃に冷
却し、そこへDMAP4.3g(35.2mmol)をすこ
しづつ加えた。さらに0℃で1時間かき混ぜた後、反応
液を氷水中に注ぎエーテルで抽出した。抽出物を硫酸銅
水溶液、炭酸ナトリウム水溶液及び食塩水で洗浄し、硫
酸マグネシウムで乾燥した後エーテルを回収し、残渣を
減圧蒸留してb.p.82〜84℃/10.5Torrの式
(4)の化合物75.7gを得た。
[Reference Example 3](±) -2,4,4-trimethyl-2-si
Synthesis of clohexenyl acetate [compound of formula (4)]  61.5 g of racemic alcohol obtained in Reference Example 2
(439 mmol), 67.3 g (659 mmol) of acetic anhydride and
And cooled to 0 ° C while stirring a mixture of 77 ml of pyridine
And put 4.3 g (35.2 mmol) of DMAP into it.
Added one by one. After further stirring at 0 ° C for 1 hour,
The liquid was poured into ice water and extracted with ether. Extract copper sulfate
Wash with aqueous solution, aqueous sodium carbonate solution and saline
After drying with magnesium acid, the ether is recovered and the residue is recovered.
Distillation under reduced pressure b. p. 82-84 ° C / 10.5 Torr
75.7 g of the compound (4) was obtained.

【0024】[0024]

【実施例1】(±)−2,4,4−トリメチル−2−シ
クロヘキセニルアセテート[式(4)の化合物]の不斉
加水分解 式(4)の化合物26.3g(145mmol)を0.1
モル燐酸バッファー(イオン交換水:メタノール=8:
2;pH7.5)1.1l中に分散させ、激しくかき混
ぜながら−10℃に冷却し、ブタ肝臓エステラーゼ(シ
グマ社製)50250unitを加えて65時間酵素分解を
行った。反応液を食塩と塩化アンモニウムで飽和させ、
エーテルで3回抽出した。抽出液を炭酸ナトリウム、食
塩水で洗浄し、炭酸マグネシウムで乾燥後エーテルを回
収し、残渣27.5gをシリカゲルクロマトグラフィー
により精製した。その結果、式(1)化合物(R)−
(+)−2,4,4−トリメチル−2−シクロヘキセン
−1−オール5.32g[b.p.63〜64℃/3To
rr;[α]D=+95.7°(21℃)(C=1.1
3、MeOH);100%e.e.]及び式(3)化合
物(S)−(−)−2,4,4−トリメチル−2−シク
ロヘキセニルアセテート17.7g[b.p.57〜5
7.5℃/2.5Torr;[α]D=−39.5°(21
℃);(C=1.10、MeOH);41%e.e.]が
得られた。
Embodiment 1(±) -2,4,4-trimethyl-2-si
Asymmetric of clohexenyl acetate [compound of formula (4)]
Hydrolysis  26.3 g (145 mmol) of the compound of formula (4)
Molar phosphate buffer (ion exchange water: methanol = 8:
2; pH 7.5) Disperse in 1.1 l and stir vigorously
While cooling to −10 ° C.
Add 50250 units and perform enzymatic degradation for 65 hours
went. The reaction was saturated with salt and ammonium chloride,
Extracted three times with ether. Extract the sodium carbonate, diet
Wash with brine, dry with magnesium carbonate and recover ether.
27.5 g of the residue was subjected to silica gel chromatography.
And purified. As a result, the compound of formula (1) (R)-
(+)-2,4,4-trimethyl-2-cyclohexene
-1-ol 5.32 g [b. p. 63-64 ° C / 3To
rr; [α]D= + 95.7 ° (21 ° C.) (C = 1.1
3, MeOH); 100% ee. And the formula (3)
Product (S)-(-)-2,4,4-trimethyl-2-cycl
17.7 g of rohexenyl acetate [b. p. 57-5
7.5 ° C / 2.5 Torr; [α]D= −39.5 ° (21
° C); (C = 1.10, MeOH); 41% ee]
Obtained.

【0025】[0025]

【実施例2】(S)−(−)−2,4,4−トリメチル
−2−シクロヘキセニルアセテート[式(3)の化合
物]の光学純度の向上 式(3)の化合物74g(407mmol)を実施例1と
同様にブタ肝臓エステラーゼで処理し、高光学純度の
(S)−(−)−2,4,4−トリメチル−2−シクロ
ヘキセニルアセテート[式(3)の化合物]49.3g
[b.p.57〜58℃/2Torr;[α]D=−97.9
°(21℃);(C=1.07、MeOH);96%
e.e.]及び式(1)の化合物18.0gを得た。
Embodiment 2(S)-(-)-2,4,4-trimethyl
-2-cyclohexenyl acetate [compound of formula (3)
Of optical purity of  74 g (407 mmol) of the compound of formula (3)
Similarly treated with porcine liver esterase to obtain high optical purity
(S)-(-)-2,4,4-trimethyl-2-cyclo
Hexenyl acetate [compound of formula (3)] 49.3 g
[B. p. 57-58 ° C / 2 Torr; [α]D= -97.9
° (21 ° C); (C = 1.07, MeOH); 96%
ee] and 18.0 g of the compound of formula (1).

【0026】[0026]

【実施例3】(S)−(−)−2,4,4−トリメチル
−2−シクロヘキセン−1−オール[式(2)の化合
物]の合成 実施例2で得られた式(3)の化合物49g(270
mmol,96%e.e.)をメタノール750mlに溶解
し、炭酸カリウム75.5g(550mmol)を加えて室
温で2時間かき混ぜた後、減圧下にメタノールを回収し
残渣を水で希釈し、エーテルで抽出した。抽出液を洗
浄、乾燥後エーテルを回収して粗製の式(2)の化合物
42g(96%e.e.)を得た。
Embodiment 3(S)-(-)-2,4,4-trimethyl
-2-cyclohexen-1-ol [compound of the formula (2)
Synthesis of  49 g of the compound of the formula (3) obtained in Example 2 (270 g)
mmol, 96% ee) in 750 ml of methanol
And add 75.5 g (550 mmol) of potassium carbonate
After stirring at room temperature for 2 hours, recover methanol under reduced pressure.
The residue was diluted with water and extracted with ether. Wash the extract
After purification and drying, the ether is recovered and the crude compound of formula (2) is recovered.
42 g (96% ee) were obtained.

【0027】次いで、これにピリジン500ml及びD
MAP2.93g(24mmol)を加え、かき混ぜながら
3,5−ジニトロベンゾイルクロライド83g(360
mmol)を少しづつ加えた。室温で3時間かき混ぜ反応を
行った後、反応液を氷水中に注ぎ、エーテルで数回抽出
した。抽出液を稀塩酸水溶液、炭酸ナトリウム水溶液、
食塩水で洗浄後硫酸マグネシウムで乾燥し、エーテルを
回収して式(5)の化合物の粗結晶87gを得た。これ
をイソプロピルエーテルから再結晶し、純粋な式(5)
の化合物77.5g[m.p.130〜131℃、[α]
D=−118.5°(21℃)、(C=1.04;CHC
3)]を得た。
Then, 500 ml of pyridine and D
2.93 g (24 mmol) of MAP were added, and 83 g (360 g) of 3,5-dinitrobenzoyl chloride was added with stirring.
mmol) was added little by little. After stirring for 3 hours at room temperature, the reaction solution was poured into ice water and extracted several times with ether. Extract solution is diluted hydrochloric acid aqueous solution, sodium carbonate aqueous solution,
After washing with brine and drying over magnesium sulfate, the ether was recovered to give 87 g of crude crystals of the compound of formula (5). This was recrystallized from isopropyl ether to give pure formula (5)
77.5 g [mp 130-131 ° C, [α]
D = -118.5 ° (21 ° C.), (C = 1.04; CHC
l 3 )].

【0028】この式(5)の化合物76.5g(229
mmol)をメタノールとジクロロメタンの混合溶媒(1:
1)1050mlに溶解し、炭酸カリウム59.5g
(431mmol)を加え、室温で3時間かき混ぜた後、溶
媒を除去して残渣をシリカゲルカラムクロマトグラフィ
ーで精製した。その結果、光学純度100%e.e.の
(S)−(−)−2,4,4−トリメチル−2−シクロ
ヘキセン−1−オール[式2)の化合物;b.p.83〜
85℃/13.5Torr;[α]D=−95.9°(2
1℃),(C=1.02,MeOH)]34.5gを得
た。
76.5 g (229) of the compound of formula (5)
mmol) in a mixed solvent of methanol and dichloromethane (1:
1) Dissolve in 1050 ml and add 59.5 g of potassium carbonate
(431 mmol) was added and the mixture was stirred at room temperature for 3 hours, the solvent was removed, and the residue was purified by silica gel column chromatography. As a result, a compound of (S)-(-)-2,4,4-trimethyl-2-cyclohexen-1-ol [formula 2] having an optical purity of 100% ee;
85 ° C./13.5 Torr; [α] D = −95.9 ° (2
1 ° C.), (C = 1.02, MeOH)].

【0029】[0029]

【発明の効果】本発明によれば、ラセミ体の2,4,4
−トリメチル−2−シクロヘキセニルアセテートをエス
テル分解酵素で不斉加水分解することにより光学的に極
めて高純度の(R)−(+)−及び(S)−(−)−
2,4,4−トリメチル−2−シクロヘキセン−1−オ
ールを容易に合成することができる。すなわち本発明に
よれば、新規化合物である2,4,4−トリメチル−2
−シクロヘキセン−1−オールの両鏡像体を工業的に極
めて有利な方法によって簡便で且つ高純度、高収率しか
も高光学純度をもって合成することができる。本発明方
法によって得られる光学活性な2,4,4−トリメチル
−2−シクロヘキセン−1−オールは、例えば、香料化
合物、農薬などの合成中間体として極めて有用な化合物
である。
According to the present invention, the racemic 2,4,4
-Asymmetric hydrolysis of trimethyl-2-cyclohexenyl acetate with an esterase to produce (R)-(+)-and (S)-(-)-with extremely high optical purity.
2,4,4-trimethyl-2-cyclohexen-1-ol can be easily synthesized. That is, according to the present invention, the novel compound 2,4,4-trimethyl-2
Both enantiomers of -cyclohexen-1-ol can be synthesized simply and with high purity, high yield, and high optical purity by an industrially extremely advantageous method. The optically active 2,4,4-trimethyl-2-cyclohexen-1-ol obtained by the method of the present invention is a very useful compound as a synthetic intermediate such as a fragrance compound and an agricultural chemical.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) C12P 41/00 C07C 27/02 C07C 35/18 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int. Cl. 6 , DB name) C12P 41/00 C07C 27/02 C07C 35/18 CA (STN) REGISTRY (STN)

Claims (4)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 下記式(1) 【化1】 で表される(R)−(+)−2,4,4−トリメチル−
2−シクロヘキセン−1−オール。
[Claim 1] The following formula (1) (R)-(+)-2,4,4-trimethyl- represented by
2-cyclohexen-1-ol.
【請求項2】下記式(2) 【化2】 で表される(S)−(−)−2,4,4−トリメチル−
2−シクロヘキセン−1−オール。
(2) The following formula (2): (S)-(-)-2,4,4-trimethyl- represented by
2-cyclohexen-1-ol.
【請求項3】 下記式(4) 【化3】 式中、Acはアセチル基を示す、 で表される(±)−2,4,4−トリメチル−2−シク
ロヘキセニルアセテートをエステラーゼで不斉加水分解
し、次いで、該分解物より下記式(1) 【化4】 で表される化合物を分離採取することを特徴とする
(R)−(+)−2,4,4−トリメチル−2−シクロ
ヘキセン−1−オールの製法。
3. The following formula (4): Wherein, Ac is asymmetric hydrolysis an acetyl group, in represented the (±)-2,4,4-trimethyl-2-cyclohexenyl acetate in esterase, then the following equation from the hydrolyzate ( 1) A method for producing (R)-(+)-2,4,4-trimethyl-2-cyclohexen-1-ol, which comprises separating and collecting a compound represented by the formula:
【請求項4】 下記式(3) 【化5】 式中、Acはアセチル基を示す、で表される(S)−
(−)−2,4,4−トリメチル−2−シクロヘキセニ
ルアセテートを加水分解処理し、次いで3,5−ジニト
ロベンゾイルハライドと反応せしめ、下記式(5) 【化6】 式中、DNBは3,5−ジニトロベンゾイル基を示す、 で表されるジニトロベンゾイル誘導体に導き、該誘導体
をアルカリで処理することを特徴とする下記式(2) 【化7】 で表される(S)−(−)−2,4,4−トリメチル−
2−シクロヘキセン−1−オールの製法。
4. The following formula (3): In the formula, Ac represents an acetyl group.
(-)-2,4,4-Trimethyl-2-cyclohexenyl acetate is hydrolyzed and then reacted with 3,5-dinitrobenzoyl halide to give the following formula (5): In the formula, DNB represents a 3,5-dinitrobenzoyl group, and is derived into a dinitrobenzoyl derivative represented by the following formula: and the derivative is treated with an alkali. (S)-(-)-2,4,4-trimethyl- represented by
Production method of 2-cyclohexen-1-ol.
JP6239391A 1991-03-05 1991-03-05 Optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and method for producing the same Expired - Fee Related JP2877976B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6239391A JP2877976B2 (en) 1991-03-05 1991-03-05 Optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6239391A JP2877976B2 (en) 1991-03-05 1991-03-05 Optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and method for producing the same

Publications (2)

Publication Number Publication Date
JPH04278097A JPH04278097A (en) 1992-10-02
JP2877976B2 true JP2877976B2 (en) 1999-04-05

Family

ID=13198845

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6239391A Expired - Fee Related JP2877976B2 (en) 1991-03-05 1991-03-05 Optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and method for producing the same

Country Status (1)

Country Link
JP (1) JP2877976B2 (en)

Also Published As

Publication number Publication date
JPH04278097A (en) 1992-10-02

Similar Documents

Publication Publication Date Title
US4337352A (en) Separation of enantiomers of chiral carboxylic acids
JPH1180149A (en) Optical resolution of (+,-)-chromancarboxylic acid
JP2877976B2 (en) Optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and method for producing the same
EP0759424B1 (en) Process for producing optically active 2-hydroxy-4-arylbutyric acid or its ester, and intermediate therefor
EP0614986A1 (en) Enzymatic racemate cleavage of 2-pipéridine alkylcarboxylates and their use as synthesis intermediates
JP3673603B2 (en) Process for producing optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and esters thereof
JP2002544252A (en) Process for preparing R-(-)-carnitine from S-(-)-chlorosuccinic acid or derivatives thereof
JP2776995B2 (en) Process for producing (R)-(+)-dihydro-α-ionone and novel intermediate thereof
EP0071500B1 (en) Process for the preparation of 4-aminobutyramide
JP3907787B2 (en) Method for producing benzoic acid derivative
JPH04308550A (en) Method of stereoselectively converting diol into alcohol
JP2804654B2 (en) Method for producing (S)-(-)-dehydro-α-damaschol
US5243070A (en) Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid
JP3756266B2 (en) Method for producing optically active α-ionone
JPH10218847A (en) Production of tartranilic acid
JP2824159B2 (en) (S)-(-)-α-Damascon production method
JP2756790B2 (en) Method for producing optically active cyclopentenol derivative
JP2974181B2 (en) A new method for producing cyclobutanol
JP4133328B2 (en) Preparation of 3- [2-{(methylsulfonyl) oxy} ethoxy] -4- (triphenylmethoxy) -1-butanol, methanesulfonate
JP3829266B2 (en) Optically active amino acid ester, method for producing the same, and method for producing optically active 2-methoxycyclohexanol
JPH09241227A (en) New optical resolution agent
KR100503267B1 (en) Method for the preparation of 2-acetyloxy-4-trifluoromethyl benzoic acid
JPH08119958A (en) Production of optically active chroman compound
JPH0415787B2 (en)
JP2002167381A (en) Optical resolution method of (±)-6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid

Legal Events

Date Code Title Description
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080122

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 10

Free format text: PAYMENT UNTIL: 20090122

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090122

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100122

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees